Condition
Eye Diseases clinical trials and research
As of November 12, 2026, Find a Trial lists 22 Eye Diseases clinical trials that are recruiting, at sites in 20 countries (most in United States (13), France (2), China (2)). 1 was first registered in the last 30 days. By phase: Phase 1 (2), Phase 2 (2), Phase 3 (2), Phase 4 (1). There are also 8 NIH-funded research projects on Eye Diseases, with $6.0 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 22Clinical trials
- 8NIH research projects
- 1New in 30 days
- 20Countries
Newest Eye Diseases clinical trials
All recruiting trials (22)
-
ETHY-001 safety and activity in Thyroid Eye Disease (TED)
This study tests ETHY-001 versus placebo to see if it is safe, tolerable, and shows activity in people with thyroid eye disease.
-
Autologous Serum Tears with Hyaluronate vs Standard Serum Tears for Moderate-to-Severe Dry Eye
This study tests whether adding sodium hyaluronate to autologous serum eye drops provides better relief for adults with moderate-to-severe dry eye in one eye, compared with the standard serum drops in the other eye.
-
Two approaches to repeat eyelid surgery for post-operative trichiasis
This project will try whether the newer Bevel-Rotate Advancement Procedure (B-RAP) or the standard Bilamellar Tarsal Rotation (BLTR) gives better results for people in Tanzania who need repeat surgery for post-operative trachomatous trichiasis.
-
How TRYPTYR affects quality of life and the ability to work for people with dry eye
This one-month test will see if TRYPTYR (acoltremon) eye drops help adults with chronic dry eye produce more tears, reduce symptoms, and improve their ability to do work.
-
Course of EYS-associated retinitis pigmentosa in adults from Russia and former CIS
We will follow adults with pathogenic EYS gene variants from Russia and former CIS for four years to try to find reliable vision and retinal measures for future treatments.
-
Dapagliflozin (an SGLT2 inhibitor) for slowing geographic atrophy in dry AMD
This trial will test whether taking dapagliflozin once daily can slow the growth of geographic atrophy in people aged 50 and older with dry age-related macular degeneration.
-
Michigan telemedicine screening for glaucoma and other sight‑threatening eye problems
This program tests whether a technology-enhanced telemedicine screening finds glaucoma, diabetic eye disease, and visually significant cataracts more often than a standard optometric exam for patients at a community health center.
-
Sepofarsen injections for LCA10 due to the CEP290 p.Cys998X mutation
This study will test whether sepofarsen eye injections can improve vision in children and adults with LCA10 caused by the CEP290 c.2991+1655A>G (p.Cys998X) mutation.
-
Auto-aligning handheld OCT for adult and pediatric retinal imaging
We will test a new handheld OCT device that automatically aligns to capture retinal images in healthy adults, adult eye patients, and children.
-
Assessing patterns of eye diseases in patients at Sohag University Hospital
This study looks at how common different eye diseases are among patients visiting the Eye Investigation Unit at Sohag University Hospital to see if there are any differences between men and women.
-
Precision diagnosis and therapy for rare eye and neuromuscular diseases
This study is testing new ways to find the genetic causes of rare eye and muscle diseases to help create more personalized treatments for patients.
-
Using AI to identify eye and brain conditions from fundus photographs in emergency settings
This study is testing whether artificial intelligence can help doctors quickly spot eye and brain problems from photos taken in emergency rooms to improve patient care.
-
Evaluating a stem cell treatment for geographic atrophy from dry age-related macular degeneration.
This study is testing a new stem cell treatment for people with geographic atrophy from dry age-related macular degeneration to see if it can help improve their vision.
-
Evaluating linsitinib for thyroid eye disease
This study is testing if a new drug called linsitinib can help people with moderate to severe thyroid eye disease who haven't improved with other treatments.
-
Observational study on eye health in the elderly
This study is looking at how lifestyle and genetics affect eye health in older people to help understand the risks for common eye diseases like glaucoma and macular degeneration.
-
Using stem cells from umbilical cords to treat non-arteritic ischemic optic neuropathy
This study is testing if using stem cells from umbilical cords can help people with non-arteritic ischemic optic neuropathy improve their vision and overall eye health.
-
Treatment for bleeding in the eye due to wet macular degeneration
This study is testing if a new surgical treatment combined with injections can help older adults with bleeding in the eye from wet macular degeneration see better than the usual injections alone.
-
Using laser treatment to manage glaucoma in patients receiving a Boston keratoprosthesis
This study is testing a laser treatment to see if it can help manage glaucoma in patients who have received an artificial cornea to improve their vision.
-
Comparing eye disease prevalence in diabetic and healthy children
This study looks at how common eye diseases are in children with diabetes compared to healthy kids to help improve eye care for those with diabetes.
-
A comprehensive registry for eye diseases
This study is creating a national database to help eye doctors track and improve the care they provide to patients with eye diseases.
-
Using adaptive optics to improve retinal imaging
This study is testing whether a new imaging technique can help doctors take better pictures of the retina to improve diagnosis and treatment for people with eye diseases.
-
Screening for participants with eye diseases
This study is looking for people with eye diseases to see if they can join other research studies and to collect samples for future eye disease research.
NIH-funded research (8)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Biobank tools to better understand and manage eye diseases
A study to connect eye disease genetics with real-world health data to improve understanding and care for eye conditions.
-
Telehealth glaucoma screening for high-risk patients
A new telemedicine program will check for glaucoma in Black and Latino people at community clinics to catch and manage eye disease early.
-
Improving imaging and treatments for the retina, RPE, and choroid in macular degeneration
Researchers are developing high-resolution live imaging and targeted approaches to track and treat changes in the retina, retinal pigment epithelium, and choroid that lead to inherited and age-related macular degeneration.
-
Long-term safety and vision outcomes after immune-suppressing treatment for eye inflammation
This project looks at long-term health, cancer risk, and vision outcomes in people who received systemic immune-suppressing drugs for non-infectious eye inflammation.
-
New ways to use telehealth for finding and managing glaucoma and other serious eye conditions in people at higher risk
This project explores if using telemedicine can help find glaucoma and other serious eye problems earlier in Black and Latino individuals and those with limited access to eye care.
-
Improving understanding and management of eye diseases using biobank data
This study is looking at how your genes might be linked to eye diseases, especially for people of African descent, by combining genetic information with health records to help doctors better understand and manage these conditions.
-
Using telehealth to detect and manage glaucoma in high-risk groups
This study is looking at how well telemedicine can help find glaucoma and other eye problems early in Black and Latino communities that may not have easy access to eye care, and it’s inviting people to take part in this important research.
-
Investigating a new model for understanding eye development disorders
This study is exploring how problems in eye development can lead to vision issues, and it's for anyone interested in understanding eye disorders better; researchers are creating a new model using special stem cells to see how different genes affect the way our eyes form, which could help in finding new treatments.
Related topics
Quick answers
How many Eye Diseases clinical trials are recruiting right now?
22, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 20 countries. The most sites are in United States (13 trials), France (2 trials), China (2 trials), Canada (2 trials), Germany (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 2, Phase 3: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.